Close Menu

NEW YORK (GenomeWeb) – Clinical genomic testing company Variantyx has received a $7 million investment from Israeli firm Pitango Venture Capital.

Pitango, based in Herzliya, said today that the funding round is part of its new Pitango HealthTech Fund, which the firm aims to close at $150 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Sponsored by

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.